• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非标准产科抗磷脂综合征的妊娠结局:91例患者队列分析

Pregnancy Outcomes in Non-Criteria Obstetric Antiphospholipid Syndrome: Analysis of a Cohort of 91 Patients.

作者信息

Beça Sara, Baños Núria, Borrell Maria, Ruiz-Ortiz Estíbaliz, Pérez-Isidro Albert, Cervera Ricard, Reverter Joan Carles, Tàssies Dolores, Espinosa Gerard

机构信息

Department of Autoimmune Diseases, Reference Centre for Systemic Autoimmune Diseases (UEC/CSUR) of the Catalan and Spanish Health Systems-Member of ERNReCONNET, Hospital Clínic, University of Barcelona, 08036 Barcelona, Catalonia, Spain.

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Catalonia, Spain.

出版信息

J Clin Med. 2024 Dec 23;13(24):7862. doi: 10.3390/jcm13247862.

DOI:10.3390/jcm13247862
PMID:39768785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11728320/
Abstract

: The clinical and laboratory features of patients with non-criteria obstetric antiphospholipid syndrome (NC-OAPS), as well as their pregnancy outcomes and ideal treatment are not clearly determined. The aim of this study is to describe the characteristics and outcomes of pregnancies in NC-OAPS and compare them with an obstetric APS (OAPS) cohort. : This is a retrospective study conducted on a cohort of women referred to a high-risk obstetric unit of a tertiary hospital. Women that were classified as having OAPS or NC-OAPS were included and compared in terms of clinical and laboratory characteristics, management, and subsequent pregnancy outcomes. : We identified 107 women with 143 pregnancies, 91 with NC-OAPS and 16 with OAPS. There were no differences in demographic features between both groups. Women with NC-OAPS were more likely to have recurrent implantation failure and were predominantly positive for a single antiphospholipid antibody (aPL) subtype. Both groups were treated similarly (low dose aspirin plus low molecular weight heparin in 87.4% of NC-OAPS and 83.3% of OAPS, > 0.05). Live birth rate (82.4% and 75.0%, respectively, > 0.05) and adverse pregnancy outcomes (31.6% vs. 37.5%, > 0.05) in subsequent pregnancies during follow-up were also similar between groups. : This study revealed differences in the previous pregnancy morbidity and aPL profiles in women with NC-OAPS and OAPS, although the therapeutic approach and the outcomes of subsequent pregnancies were similar in both groups.

摘要

非标准型产科抗磷脂综合征(NC - OAPS)患者的临床和实验室特征、妊娠结局及理想治疗方法尚未明确确定。本研究旨在描述NC - OAPS患者妊娠的特征和结局,并与产科抗磷脂综合征(OAPS)队列进行比较。

这是一项对转诊至三级医院高危产科病房的女性队列进行的回顾性研究。纳入被分类为患有OAPS或NC - OAPS的女性,并在临床和实验室特征、管理及后续妊娠结局方面进行比较。

我们确定了107名女性的143次妊娠,其中91名患有NC - OAPS,16名患有OAPS。两组在人口统计学特征上无差异。NC - OAPS女性更易发生反复种植失败,且主要为单一抗磷脂抗体(aPL)亚型阳性。两组治疗方式相似(87.4%的NC - OAPS患者和83.3%的OAPS患者接受低剂量阿司匹林加低分子量肝素治疗,P>0.05)。随访期间后续妊娠的活产率(分别为82.4%和75.0%,P>0.05)及不良妊娠结局(分别为31.6%和37.5%,P>0.05)在两组间也相似。

本研究揭示了NC - OAPS和OAPS女性既往妊娠发病率及aPL谱的差异,尽管两组的治疗方法及后续妊娠结局相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/513c/11728320/e9156c690172/jcm-13-07862-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/513c/11728320/31cf190d7222/jcm-13-07862-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/513c/11728320/e9156c690172/jcm-13-07862-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/513c/11728320/31cf190d7222/jcm-13-07862-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/513c/11728320/e9156c690172/jcm-13-07862-g002.jpg

相似文献

1
Pregnancy Outcomes in Non-Criteria Obstetric Antiphospholipid Syndrome: Analysis of a Cohort of 91 Patients.非标准产科抗磷脂综合征的妊娠结局:91例患者队列分析
J Clin Med. 2024 Dec 23;13(24):7862. doi: 10.3390/jcm13247862.
2
Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry.产科抗磷脂综合征(OAPS)与非标准产科抗磷脂综合征(NC-OAPS)的对比研究:来自 EUROAPS 注册研究的 1640 例报告。
Rheumatology (Oxford). 2020 Jun 1;59(6):1306-1314. doi: 10.1093/rheumatology/kez419.
3
Clinical Features Between Primary Obstetric Antiphospholipid Syndrome and Non-Criteria Obstetric Antiphospholipid Syndrome and Risk Factors of Adverse Pregnancy Outcomes: A Retrospective Study of 1006 Cases.原发性产科抗磷脂综合征与非标准产科抗磷脂综合征的临床特征及不良妊娠结局的危险因素:1006 例回顾性研究。
Am J Reprod Immunol. 2024 Sep;92(3):e13931. doi: 10.1111/aji.13931.
4
Correlation of placental lesions in patients with systemic lupus erythematosus, antiphospholipid syndrome and non-criteria obstetric antiphospholipid syndrome and adverse perinatal outcomes.系统性红斑狼疮、抗磷脂综合征和非标准产科抗磷脂综合征患者的胎盘病变与不良围生期结局的相关性。
Placenta. 2023 Aug;139:92-98. doi: 10.1016/j.placenta.2023.06.013. Epub 2023 Jun 20.
5
Clinical features associated with pregnancy outcomes in women with positive antiphospholipid antibodies and previous adverse pregnancy outcomes: a real-world prospective study.抗磷脂抗体阳性且既往有不良妊娠结局的女性妊娠结局相关临床特征:一项真实世界前瞻性研究
Clin Rheumatol. 2021 Jan;40(1):193-204. doi: 10.1007/s10067-020-05203-3. Epub 2020 Jun 8.
6
[Obstetric Antiphospholipid Syndrome: Insights on the Diagnosis, Treatment, and Hot Issues].[产科抗磷脂综合征:关于诊断、治疗及热点问题的见解]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 May 20;55(3):513-520. doi: 10.12182/20240560104.
7
Clinical phenotype, treatment strategy and pregnancy outcome of non-criteria obstetric antiphospholipid syndrome.非标准产科抗磷脂综合征的临床表型、治疗策略和妊娠结局。
Am J Reprod Immunol. 2023 Jun;89(6):e13684. doi: 10.1111/aji.13684. Epub 2023 Mar 9.
8
[Clinical characteristics and pregnancy outcomes of non-criteria obstetric antiphospholipid syndrome].非标准型产科抗磷脂综合征的临床特征及妊娠结局
Zhonghua Nei Ke Za Zhi. 2021 Sep 1;60(9):812-816. doi: 10.3760/cma.j.cn112138-20210506-00329.
9
Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.产科和血栓性抗磷脂综合征患者的妊娠结局-回顾性分析及妊娠中额外治疗的综述。
Clin Rev Allergy Immunol. 2017 Aug;53(1):54-67. doi: 10.1007/s12016-016-8569-0.
10
Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review.产科抗磷脂综合征的发病机制、诊断与管理:综述
J Clin Med. 2022 Jan 28;11(3):675. doi: 10.3390/jcm11030675.

本文引用的文献

1
Recurrent miscarriage and low-titer antiphospholipid antibodies.复发性流产与低滴度抗磷脂抗体。
Clin Rheumatol. 2024 Apr;43(4):1327-1334. doi: 10.1007/s10067-023-06843-x. Epub 2024 Feb 26.
2
Antiphospholipid Syndrome: To Classify or Not to Classify?抗磷脂综合征:分类与否?
Turk J Haematol. 2024 Mar 1;41(1):37-40. doi: 10.4274/tjh.galenos.2024.2024.0003. Epub 2024 Jan 29.
3
Preconception Non-criteria Antiphospholipid Antibodies and Risk of Subsequent Early Pregnancy Loss: a Retrospective Study.抗磷脂抗体非标准预存与后续早期妊娠丢失风险:一项回顾性研究。
Reprod Sci. 2024 Mar;31(3):746-753. doi: 10.1007/s43032-023-01388-5. Epub 2023 Nov 6.
4
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.2023年美国风湿病学会/欧洲抗风湿病联盟抗磷脂综合征分类标准。
Arthritis Rheumatol. 2023 Oct;75(10):1687-1702. doi: 10.1002/art.42624. Epub 2023 Aug 28.
5
High-throughput sequencing technology facilitates the discovery of novel biomarkers for antiphospholipid syndrome.高通量测序技术有助于发现抗磷脂综合征的新型生物标志物。
Front Immunol. 2023 May 19;14:1128245. doi: 10.3389/fimmu.2023.1128245. eCollection 2023.
6
An update on the biologics for the treatment of antiphospholipid syndrome.抗磷脂综合征治疗的生物制剂最新进展。
Front Immunol. 2023 May 19;14:1145145. doi: 10.3389/fimmu.2023.1145145. eCollection 2023.
7
Non-Criteria Obstetric Antiphospholipid Syndrome: How Different Is from Sidney Criteria? A Single-Center Study.非标准产科抗磷脂综合征:与悉尼标准有何不同?一项单中心研究。
Biomedicines. 2022 Nov 15;10(11):2938. doi: 10.3390/biomedicines10112938.
8
Anticardiolipin and/or anti-β2-glycoprotein-I antibodies are associated with adverse IVF outcomes.抗心磷脂抗体和/或抗β2-糖蛋白 I 抗体与不良的 IVF 结局相关。
Front Immunol. 2022 Nov 2;13:986893. doi: 10.3389/fimmu.2022.986893. eCollection 2022.
9
Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review.非标准抗磷脂综合征与明确抗磷脂综合征的比较:系统评价。
Front Immunol. 2022 Aug 18;13:967178. doi: 10.3389/fimmu.2022.967178. eCollection 2022.
10
Presence of antiphospholipid antibodies is associated with increased implantation failure following in vitro fertilization technique and embryo transfer: A systematic review and meta-analysis.抗磷脂抗体的存在与体外受精技术和胚胎移植后着床失败增加有关:系统评价和荟萃分析。
PLoS One. 2022 Jul 27;17(7):e0260759. doi: 10.1371/journal.pone.0260759. eCollection 2022.